Treatments for acquired hypothalamic obesity, dry eye disease, primary biliary cholangitis, psoriatic arthritis, and severe leukocyte adhesion deficiency-I under review.
Independent testing through DHS RIVR program exposes meaningful separation in real-world performance across the ...
In crypto, most projects focus on speed, fees, and hype cycles. Far fewer invest in the invisible infrastructure that allows ...
Efgartigimod alfa–hyaluronidase significantly improves ocular symptoms in adults with ocular myasthenia gravis, according to phase 3 trial data.
FDA grants Breakthrough Therapy designation to luvesilocin for postpartum depression following positive results from the phase 2 RECONNECT trial.
Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment If approved, Dupixent would be the first ta ...
The cost to park on Duluth’s streets is going up from $1.50 per hour to $2.00 per hour. This change will be implemented in phases, one parking zone at a time, and will be completed sometime later in ...
Trade rejections and unexpected fees highlight the growing need for predictable, clear LEI management. UNITED KINGDOM, ...
If approved, Ojemda® (tovorafenib) is expected to be the first and only targeted medicine in European Union for children with relapsed or ...
Preliminary blinded CR rate showed 67% improvement over historical cytarabine responseRoughly 35% of the subjects treated to date represent ...
From March 1st, regulations assigning unique identification codes to each property will take effect. The national data system ...
Just like each person has unique fingerprints, every CMOS chip has a distinctive "fingerprint" caused by tiny, random manufacturing variations. Engineers can leverage this unforgeable ID for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results